Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jose H. Woodhead"'
Autor:
Jose H. Woodhead, Megan Hunt, Laura J. Handy, Karen White, Karen S. Wilcox, Timothy H. Pruess, Misty D. Smith, Fabiola Vanegas, Joel Grussendorf, Reisa K. Krumin, Karolina K. Bulaj, Erin Grussendorf
Publikováno v:
Neurochemical Research. 42:1995-2010
The series of experiments herein evaluated prototype drugs representing different mechanisms of antiseizure, antinociceptive or antidepressant action in a battery of preclinical pain models in adult male CF#1 mice (formalin, writhing, and tail flick)
Publikováno v:
Epilepsy Research. 58:1-12
N -methyl-tetramethylcyclopropanecarboxamide (MTMCD) is a new antiepileptic drug (AED) structurally related to valproic acid (VPA) that has a broad spectrum of anticonvulsant activity including models of therapy-resistant epilepsy. The purpose of thi
Autor:
Meir Bialer, H. Steve White, Boris Yagen, Nina Isoherranen, Ofer Spiegelstein, Jose H. Woodhead, Michelle Merriweather, Richard H. Finnell, Bogdan J. Wlodarczyk
Publikováno v:
British Journal of Pharmacology. 139:755-764
1 The purpose of this study was to synthesize novel valproyltaurine (VTA) derivatives including valproyltaurinamide (VTD), N-methyl-valproyltaurinamide (M-VTD), N,N-dimethyl-valproyltaurinamide (DM-VTD) and N-isopropyl-valproyltaurinamide (I-VTD) and
Autor:
Meir Bialer, Ofer Spiegelstein, Jose H. Woodhead, H. Steve White, Richard H. Finnell, Boris Yagen, Gregory D. Bennett, Karen S. Wilcox, Nina Isoherranen, Simcha Blotnik
Publikováno v:
British Journal of Pharmacology. 138:602-613
Propylisopropyl acetamide (PID) is a new chiral amide derivative of valproic acid. The purpose of this study was to evaluate the anticonvulsant activity of PID in rodent models of partial, secondarily generalized and sound-induced generalized seizure
Autor:
Michael Roeder, Volker Schurig, Brian D. Klein, H. Steve White, Boris Yagen, Meir Bialer, Nina Isoherranen, Jose H. Woodhead
Publikováno v:
Pharmaceutical Research. 20:1293-1301
Purpose. Racemic valnoctamide (VCD) is a central nervous system- active drug commercially available in Europe. VCD possesses two chiral centers and, therefore, it exists as a mixture of four stereoisomers. The purpose of this study was to evaluate th
Autor:
Boris Yagen, Nina Isoherranen, Gregory D. Bennett, Meir Bialer, Jose H. Woodhead, H. Steve White, Matthew E. Barton, Karen S. Wilcox, Richard H. Finnell
Publikováno v:
Epilepsia. 43:115-126
Summary: Purpose: The studies presented here represent our efforts to investigate the anticonvulsant activity of N-methyl-tetramethylcyclopropyl carboxamide (M-TMCD) and its metabolite tetramethylcyclopropyl carboxamide (TMCD) in various animal (rode
Publikováno v:
Epilepsia. 42:831-836
Summary: Purpose: We sought to investigate the anticonvulsant activity of the new antiepileptic drug (AED), valrocemide or TV1901 (VGD) in various animal (rodent) models of human epilepsy to determine its anticonvulsant profile and safety margin. Met
Autor:
Harold H. Wolf, Gregory S. Shen, R. Tyler McCabe, Huiling Lian, Jose H. Woodhead, Solomon S. Steiner, Christopher A. Rhodes, H. Steve White, R. Duane Sofia
Publikováno v:
Journal of Pharmaceutical Sciences. 89:867-875
Felbamate (FBM) is a novel antiepileptic drug (AED) and neuroprotectant (NP) compound that interacts with strychnine‐insensitive (SI) glycine receptors in brain (IC 50 = 374 μM). FBM concentrations required to interact with SI glycine receptors ar
Publikováno v:
Epilepsia. 41:17-20
Summary: Purpose: These studies further investigate the ability of topiramate (TPM) to enhance γ-aminobutyric acid (GABA)-mediated inhibition through a benzodiazepine-insensitive pathway. Methods: Topiramate (30 and 100 μM) enhancement of GABA (1
Publikováno v:
Epilepsy Research. 28:167-179
The anticonvulsant topiramate is effective in laboratory animals against maximal electroshock seizures, amygdala kindling, and spike-wave discharges and has demonstrated efficacy in humans for the treatment of complex partial seizures. However, its m